Fiscal Year 2014 Cost of Hospital and Medical Care Treatment Furnished by the Department of Defense Medical Treatment Facilities; Certain Rates Regarding Recovery From Tortiously Liable Third Persons, 33784 [2014-13687]
Download as PDF
<![CDATA[
33784
Federal Register / Vol. 79, No. 113 / Thursday, June 12, 2014 / Notices
Previously
established
2014 quotas
(g)
Basic class
Morphine (for sale) ...............................................................................................................................................
Nabilone ................................................................................................................................................................
Noroxymorphone (for conversion) ........................................................................................................................
Noroxymorphone (for sale) ...................................................................................................................................
Opium (powder) ....................................................................................................................................................
Opium (tincture) ....................................................................................................................................................
Oripavine ...............................................................................................................................................................
Oxycodone (for conversion) .................................................................................................................................
Oxycodone (for sale) ............................................................................................................................................
Oxymorphone (for conversion) .............................................................................................................................
Oxymorphone (for sale) ........................................................................................................................................
Pentobarbital .........................................................................................................................................................
Phenazocine .........................................................................................................................................................
Phencyclidine ........................................................................................................................................................
Phenmetrazine ......................................................................................................................................................
Phenylacetone ......................................................................................................................................................
Racemethorphan ..................................................................................................................................................
Remifentanil ..........................................................................................................................................................
Secobarbital ..........................................................................................................................................................
Sufentanil ..............................................................................................................................................................
Tapentadol ............................................................................................................................................................
Thebaine ...............................................................................................................................................................
Proposed
adjusted 2014
quotas
(g)
62,500,000
30,375
17,500,000
1,262,500
112,500
625,000
22,750,000
9,250,000
149,375,000
25,000,000
7,750,000
35,000,000
6
19
3
67,000,000
3
3,750
215,003
6,255
17,500,000
145,000,000
No change.
No change.
No change.
No change.
No change.
No change.
27,625,000
No change.
No change.
No change.
No change.
No change.
No change.
No change.
No change.
45,750,000
No change.
5,875
No change.
No change.
No change.
No change.
1,000,000
3,000,000
44,800,000
5,300,000
5,000
192,000,000
No change.
No change.
No change.
No change.
No change.
224,500,000
List I Chemicals
Ephedrine (for conversion) ...................................................................................................................................
Ephedrine (for sale) ..............................................................................................................................................
Phenylpropanolamine (for conversion) .................................................................................................................
Phenylpropanolamine (for sale) ............................................................................................................................
Pseudoephedrine (for conversion) .......................................................................................................................
Pseudoephedrine (for sale) ..................................................................................................................................
rmajette on DSK7SPTVN1PROD with NOTICES
The Deputy Administrator further
proposes that aggregate production
quotas for all other schedule I and II
controlled substances included in 21
CFR 1308.11 and 1308.12 remain at
zero. Pursuant to 21 CFR 1303.13 and 21
CFR 1315.13, upon consideration of the
relevant factors, the Deputy
Administrator may adjust the 2014
aggregate production quotas and
assessment of annual needs as needed.
Comments
Pursuant to 21 CFR 1303.11(c) and
1315.11(d), any interested person may
submit written comments on or
objections to these proposed
determinations. Based on comments
received in response to this notice, the
Deputy Administrator may hold a
public hearing on one or more issues
raised. 21 CFR 1303.11(c) and
1515.11(e). In the event the Deputy
Administrator decides to hold such a
hearing, the Deputy Administrator will
publish a notice of the hearing in the
Federal Register. After consideration of
any comments or objections, or after a
hearing, if one is held, the Deputy
Administrator will issue and publish in
the Federal Register a final order
establishing any adjustment of 2014
aggregate production quota for each
basic class of controlled substance and
VerDate Mar<15>2010
21:18 Jun 11, 2014
Jkt 232001
established assessment of annual needs
for the list I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine. 21 CFR
1303.11(c) and 1315.11(f).
Dated: June 4, 2014.
Thomas M. Harrigan,
Deputy Administrator.
[FR Doc. 2014–13804 Filed 6–11–14; 8:45 am]
BILLING CODE 4410–09–P
OFFICE OF MANAGEMENT AND
BUDGET
Fiscal Year 2014 Cost of Hospital and
Medical Care Treatment Furnished by
the Department of Defense Medical
Treatment Facilities; Certain Rates
Regarding Recovery From Tortiously
Liable Third Persons
Executive Office of the
President, Office of Management and
Budget.
ACTION: Notice.
AGENCY:
By virtue of the authority
vested in the President by Section 2(a)
of Pub. B. 87–603 (76 Stat. 593; 42
U.S.C. 2652), and delegated to the
Director of the Office of Management
and Budget by the President through
Executive Order No. 11541 of July 1,
SUMMARY:
PO 00000
Frm 00072
Fmt 4703
Sfmt 9990
1970, the rates referenced below are
hereby established. These rates are for
use in connection with the recovery
from tortiously liable third persons for
the cost of inpatient medical services
furnished by military treatment facilities
through the Department of Defense
(DoD). The rates have been established
in accordance with the requirements of
OMB Circular A–25, requiring
reimbursement of the full cost of all
services provided. The FY14 inpatient
medical rates referenced are effective
upon publication of this notice in the
Federal Register and will remain in
effect until further notice. Previously
published outpatient medical and
dental, and cosmetic surgery rates
remain in effect until further notice.
Pharmacy rates are updated
periodically. A full disclosure of the
rates is posted on DoD’s Uniform
Business Office Web site: https://
www.tricare.mil/ocfo/mcfs/ubo/mhs_
rates.cfm.
Brian C. Deese,
Deputy Director.
[FR Doc. 2014–13687 Filed 6–11–14; 8:45 am]
BILLING CODE P
E:\FR\FM\12JNN1.SGM
12JNN1
]]>Agencies
[Federal Register Volume 79, Number 113 (Thursday, June 12, 2014)]
[Notices]
[Page 33784]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13687]
=======================================================================
-----------------------------------------------------------------------
OFFICE OF MANAGEMENT AND BUDGET
Fiscal Year 2014 Cost of Hospital and Medical Care Treatment
Furnished by the Department of Defense Medical Treatment Facilities;
Certain Rates Regarding Recovery From Tortiously Liable Third Persons
AGENCY: Executive Office of the President, Office of Management and
Budget.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: By virtue of the authority vested in the President by Section
2(a) of Pub. B. 87-603 (76 Stat. 593; 42 U.S.C. 2652), and delegated to
the Director of the Office of Management and Budget by the President
through Executive Order No. 11541 of July 1, 1970, the rates referenced
below are hereby established. These rates are for use in connection
with the recovery from tortiously liable third persons for the cost of
inpatient medical services furnished by military treatment facilities
through the Department of Defense (DoD). The rates have been
established in accordance with the requirements of OMB Circular A-25,
requiring reimbursement of the full cost of all services provided. The
FY14 inpatient medical rates referenced are effective upon publication
of this notice in the Federal Register and will remain in effect until
further notice. Previously published outpatient medical and dental, and
cosmetic surgery rates remain in effect until further notice. Pharmacy
rates are updated periodically. A full disclosure of the rates is
posted on DoD's Uniform Business Office Web site: https://www.tricare.mil/ocfo/mcfs/ubo/mhs_rates.cfm.
Brian C. Deese,
Deputy Director.
[FR Doc. 2014-13687 Filed 6-11-14; 8:45 am]
BILLING CODE P
